Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-7,280
Closed -$427K 1106
2023
Q1
$427K Sell
7,280
-7,689
-51% -$424K ﹤0.01% 648
2022
Q4
$755K Buy
14,969
+7,202
+93% +$433K ﹤0.01% 671
2022
Q3
$697K Sell
7,767
-339
-4% -$35.6K ﹤0.01% 836
2022
Q2
$926K Buy
+8,106
New +$930K ﹤0.01% 837
2021
Q4
Sell
-6,800
Closed -$1.01M 1315
2021
Q3
$1.01M Hold
6,800
﹤0.01% 884
2021
Q2
$1.03M Hold
6,800
﹤0.01% 609
2021
Q1
$883K Sell
6,800
-26,324
-79% -$3.38M ﹤0.01% 852
2020
Q4
$3.98M Buy
+33,124
New +$3.25M 0.01% 555
2020
Q3
Sell
-34,382
Closed -$2.43M 851
2020
Q2
$2.43M Sell
34,382
-32,132
-48% -$2.2M 0.02% 397
2020
Q1
$4.36M Buy
66,514
+42,973
+183% +$3.42M 0.03% 286
2019
Q4
$1.93M Buy
+23,541
New +$1.81M 0.01% 559
2019
Q3
Sell
-89,315
Closed -$7.68M 895
2019
Q2
$7.68M Sell
89,315
-84,250
-49% -$6.85M 0.06% 256
2019
Q1
$13.9M Buy
173,565
+7,362
+4% +$551K 0.09% 222
2018
Q4
$10.2M Buy
166,203
+37,515
+29% +$2.54M 0.08% 219
2018
Q3
$9.25M Buy
128,688
+6,136
+5% +$386K 0.05% 284
2018
Q2
$6.43M Buy
122,552
+6,664
+6% +$313K 0.03% 346
2018
Q1
$5.03M Buy
115,888
+46,077
+66% +$2.12M 0.03% 363
2017
Q4
$3.39M Buy
69,811
+28,574
+69% +$1.44M 0.03% 351
2017
Q3
$2.1M Buy
41,237
+19,486
+90% +$933K 0.02% 406
2017
Q2
$937K Buy
21,751
+2,277
+12% +$94.6K 0.01% 416
2017
Q1
$792K Buy
+19,474
New +$718K 0.01% 431

Other funds holding OMCL

Natixis's OMCL Position: Q2 2023 in Review

Natixis sold out of Omnicell (OMCL) in Q2 2023, closing a stake of 7,280 shares — an estimated $427K sold.

Natixis first reported a position in OMCL in Q1 2017 and held it in 21 quarters. The position peaked at $13.9M in Q1 2019. 313 funds tracked by Wall St. Rank hold OMCL as of Q2 2023.

  • Natixis reported no remaining Omnicell position as of Q2 2023 after selling out during the quarter.
  • Natixis sold 7,280 Omnicell shares in Q2 2023, an estimated $427K.
  • Natixis first reported a position in Omnicell in Q1 2017 and held it in 21 quarters.
  • Natixis's Omnicell position peaked at $13.9M in Q1 2019.
  • 313 funds tracked by Wall St. Rank held Omnicell as of Q2 2023.

Based on Natixis's 13F filing for Q2 2023, filed 11 Aug 2023.